Observational study to assess frailty of subjects during ZOSTER-006 and ZOSTER-022 and HZ efficacy, immunogenicity and safety of HZ/su by frailty status (ZOSTER-064)

03/12/2020
23/04/2024
EU PAS number:
EUPAS38374
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-204878-protocol-redact

English (1.3 MB - PDF) View document
Study results
Study results

gsk-204878-clinical-study-report-redact-01

English (8.52 MB - PDF) View document

gsk-204878-clinical-study-report-redact-02

English (9.49 MB - PDF) View document
Study report
Other information